Log In
BCIQ
Print this Print this
 

NYX-2925

  Manage Alerts
Collapse Summary General Information
Company Aptinyx Inc.
DescriptionSmall molecule that acts as an NMDA receptor functional glycine-site partial agonist
Molecular Target NMDA receptor
Mechanism of ActionNMDA receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Neurology (unspecified)
Indication DetailsTreat neurological disorders
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today